D
Adaptive Biotechnologies Corporation ADPT
$7.94 $0.425.59%
Recommendation
Sell
Prev Close
$7.52
Volume
2,191,724
Avg Vol (90D)
1,640,674
Market Cap
$1.12B
Dividend & Yield
--
52-Week Range
$2.28 - $9.01
P/E (TTM)
--
EPS (TTM)
-$1.09
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Adaptive Biotechnologies (ADPT, $7.52) entered Uptrend as Momentum indicator ascends above 0 level on Apr 01, 2025
4/2/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $7.52) Stochastic Oscillator left the oversold zone on April 01, 2025
4/2/2025 - Tickeron - Stocks
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - Here's What Happened
4/1/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $7.43) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 31, 2025
4/1/2025 - Tickeron - Technical Analysis
Adaptive Biotechnologies (ADPT, $7.43) entered Downtrend as Momentum indicator drops below 0 level on Mar 31, 2025
4/1/2025 - Tickeron - Technical Analysis
Analysts Anticipate 27% Upside For The Holdings of VB
4/1/2025 - ETF Channel
Even though Adaptive Biotechnologies (NASDAQ:ADPT) has lost US$147m market cap in last 7 days, shareholders are still up 147% over 1 year
3/31/2025 - Simply Wall St
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)
3/31/2025 - TipRanks Financial Blog
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 8.2% - Here's What Happened
3/29/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $7.67) price exceeded its 50-day Moving Average on March 28, 2025
3/29/2025 - Tickeron - Stocks
Fox Run Management L.L.C. Invests $120,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
3/29/2025 - Ticker Report
Adaptive Biotechnologies (ADPT, $8.22) Stochastic Oscillator left the overbought zone on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Insider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) Insider Sells 1,698 Shares of Stock
3/27/2025 - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week High - Here's Why
3/25/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $8.66) price may drop as it broke higher Bollinger Band on Mar 24, 2025
3/25/2025 - Tickeron - Stocks
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week High - Here's Why
3/24/2025 - Ticker Report
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Here's What Happened
3/22/2025 - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Raised to "Buy" at The Goldman Sachs Group
3/22/2025 - MarketBeat
Adaptive Biotechnologies (ADPT, $8.4) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 21, 2025
3/22/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $8.4) Stochastic Oscillator left the overbought zone on March 21, 2025
3/22/2025 - Tickeron - Stocks
Adaptive Biotechnologies (ADPT, $8.4) entered Uptrend as Momentum indicator ascends above 0 level on Mar 21, 2025
3/22/2025 - Tickeron - Stocks
Analyst Expectations For Adaptive Biotechnologies's Future
3/21/2025 - Benzinga
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Here's What Happened
3/21/2025 - Ticker Report
Adaptive Biotechnologies (ADPT, $7.75) price moved above its 50-day Moving Average on March 20, 2025
3/21/2025 - Tickeron - Stocks
Adaptive Biotechnologies just upgraded at Goldman Sachs, here's why
3/21/2025 - The Fly
Income Statement
Total Revenue (TTM)
$178.96M
EBITDA (TTM)
-$136.09M
EBIT (TTM)
-$155.34M
Net Income (TTM)
-$159.49M
Balance Sheet
Total Assets (Q)
$539.38M
Total Debt (Q)
$222.67M
Total Liabilities (Q)
$336.89M
Book Value Per Share (Q)
$1.37
Cash Flow
Cash from Operations (TTM)
-$95.21M
Cash from Investing (TTM)
$77.79M
Cash from Financing (TTM)
$241.00K
Net Change in Cash (TTM)
-$17.18M
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
2.48
7-Day Total Return
-8.31%
30-Day Total Return
-5.14%
60-Day Total Return
10.28%
90-Day Total Return
77.23%
Year to Date Total Return
28.27%
1-Year Total Return
166.44%
2-Year Total Return
-8.84%
3-Year Total Return
-45.43%
5-Year Total Return
-71.77%
52-week Low
Apr 19, 2024 - $2.28
52-week High
Mar 24, 2025 - $9.01
Valuation
Market Cap
$1.12B - Small Cap
Enterprise Value
$1.08B
Price/Sales (TTM)
6.21
Price/Book (Q)
5.48
Dividends and Shares
Shares Outstanding
147.68M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.adaptivebiotech.com
Phone Number
206 659 0067
Address
1165 Eastlake Avenue East
Seattle, WA 98109
Country
United States
Year Founded
2009
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing... more
NASDAQ 04/02/2025 4:00PM Eastern Quotes delayed
Weiss Ratings